Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.Robert H. Collins, John Nemunaitis, Ofer Shpilberg et al.|Journal of Clinical Oncology|1997Cited by 1.3k
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative TherapySergio Giralt, Richard E. Champlin, James Gajewski et al.|Blood|1997Cited by 1.2k
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.Issa F. Khouri, Richard E. Champlin, Michael J. Keating et al.|Journal of Clinical Oncology|1998Cited by 927
Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationSergio Giralt, Richard E. Champlin, Peter F. Thall et al.|Blood|2001Cited by 570
Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationSergio Giralt, Richard E. Champlin, Peter F. Thall et al.|Blood|2001Cited by 516